Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * English speaking adult (18 years or older at enrollment) * Is at least 6 months post-diagnosis and a) is currently undergoing lymphoma treatment (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other) with evidence of treatment response or disease control; or b) has completed lymphoma treatment (e.g., chemotherapy/immunotherapy/radiation therapy, surgery or other) within the past 2 years and has disease control at treatment completion; patients may still be on maintenance treatment to prolong disease control. Exclusion Criteria: * Has not initiated treatment for lymphoma. * Has worsening, progressive, or uncontrolled disease that is not responding to treatment. * Active Psychiatric, medical or cognitive comorbidity as determined by site PI or treating clinician * Unwilling or unable to participate using telehealth platform
About the study
The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.
What is being tested
- Enhanced Usual Care (other)
- SMART3RP-Lymphoma (other)
Sponsor: Massachusetts General Hospital · Participants: 254 · Started: Sep 3, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT07014293
Locations in the U.S.
| Massachusetts | Mass General Brigham, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.